BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9531261)

  • 1. Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft".
    Jiang SP; Vacchio MS
    J Immunol; 1998 Apr; 160(7):3086-90. PubMed ID: 9531261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells.
    Zhang HG; Su X; Liu D; Liu W; Yang P; Wang Z; Edwards CK; Bluethmann H; Mountz JD; Zhou T
    J Immunol; 1999 Feb; 162(3):1423-30. PubMed ID: 9973398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal immunization with a soluble TCR-Ig chimeric protein: long term, V beta-8 family-specific suppression of T cells by maternally transferred antibodies.
    McKeever U; Khandekar S; Jesson M; Newcomb J; Gregory P; Naylor J; Haskins K; Jones B
    J Immunol; 1997 Dec; 159(12):5936-45. PubMed ID: 9550391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to maternal immunoglobulins: resilience of the specific T cell repertoire in spite of long-lasting perturbations.
    Faure M; Calbo S; Kanellopoulos J; Drapier AM; Cazenave PA; Rueff-Juy D
    J Immunol; 1999 Dec; 163(12):6511-9. PubMed ID: 10586043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells.
    Marth T; Zeitz M; Ludviksson BR; Strober W; Kelsall BL
    J Immunol; 1999 Jun; 162(12):7233-40. PubMed ID: 10358170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy.
    Vacchio MS; Hodes RJ
    J Immunol; 2005 Apr; 174(8):4657-61. PubMed ID: 15814689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilising T cell receptor transgenic mice to define mechanisms of maternal T cell tolerance in pregnancy.
    Moldenhauer LM; Hayball JD; Robertson SA
    J Reprod Immunol; 2010 Dec; 87(1-2):1-13. PubMed ID: 20615552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility and resistance to antigen-induced apoptosis in the thymus of transgenic mice.
    Tarazona R; Williams O; Moskophidis D; Smyth LA; Tanaka Y; Murdjeva M; Wack A; Mamalaki C; Kioussis D
    J Immunol; 1998 Jun; 160(11):5397-403. PubMed ID: 9605140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal growth modified by natural and induced changes in maternal reactivity.
    Breyere EJ
    Cancer Res; 1976 Sep; 36(9 PT 2):3441-5. PubMed ID: 975102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow inhibits T-cell activation and clonal expansion in vitro.
    George JF; Lu A; Thomas JM; Kirklin JK; Pinderski LJ
    Transplantation; 2003 Jul; 76(1):237-43. PubMed ID: 12865816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fetus and the maternal immune system: pregnancy as a model to study peripheral T-cell tolerance.
    Vacchio MS; Jiang SP
    Crit Rev Immunol; 1999; 19(5-6):461-80. PubMed ID: 10647746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The persistence of paternal antigens in the maternal body is involved in regulatory T-cell expansion and fetal-maternal tolerance in murine pregnancy.
    Zenclussen ML; Thuere C; Ahmad N; Wafula PO; Fest S; Teles A; Leber A; Casalis PA; Bechmann I; Priller J; Volk HD; Zenclussen AC
    Am J Reprod Immunol; 2010 Mar; 63(3):200-8. PubMed ID: 20055792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo-developed T cells have compromised response to existing alloantigens: using Ld-specific transgenic 2C T cells as tracers in a mouse heart transplantation model.
    Luo H; Chen H; Qi S; Loh D; Daloze P; Veillette A; Xu D; Wu J
    J Immunol; 1998 Jul; 161(1):73-82. PubMed ID: 9647209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The maternal immune system's interaction with circulating fetal cells.
    Bonney EA; Matzinger P
    J Immunol; 1997 Jan; 158(1):40-7. PubMed ID: 8977173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-induced unresponsiveness results in altered T cell signaling.
    McKay DB; Irie HY; Hollander G; Ferrara JL; Strom TB; Li Y; Burakoff SJ
    J Immunol; 1999 Dec; 163(12):6455-61. PubMed ID: 10586036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.
    Mellor AL; Sivakumar J; Chandler P; Smith K; Molina H; Mao D; Munn DH
    Nat Immunol; 2001 Jan; 2(1):64-8. PubMed ID: 11135580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central T cell tolerance in lupus-prone mice: influence of autoimmune background and the lpr mutation.
    Fatenejad S; Peng SL; Disorbo O; Craft J
    J Immunol; 1998 Dec; 161(11):6427-32. PubMed ID: 9834135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.